Standout Papers

A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy 2024 202641
  1. A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy (2024)
    Richard Lafayette, Sean Barbour et al. Kidney International

Immediate Impact

46 standout
Sub-graph 1 of 21

Citing Papers

Pesticides impacts on human health and the environment with their mechanisms of action and possible countermeasures
2024 Standout
KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS
2024 Standout
3 intermediate papers

Works of Sean Barbour being referenced

An overview of the British Columbia Glomerulonephritis network and registry: integrating knowledge generation and translation within a single framework
2013
Venous Thromboembolism in Patients with Membranous Nephropathy
2011
and 1 more

Author Peers

Author Last Decade Papers Cites
Sean Barbour 304 86 68 91 37 426
Keita Hirano 276 110 53 72 43 414
Atsumi Harada 236 66 125 61 43 477
Kazuro Kanatsu 274 95 79 53 33 479
Shigehiro Uezono 150 187 162 25 22 427
X. Kyndt 67 222 83 49 29 434
Durga Kanigicherla 353 186 69 159 27 384
Min Chen 270 212 92 30 32 511
Takashi Iwakiri 111 122 88 16 19 394
Andrea Hinojosa‐Azaola 59 180 44 71 44 414
Ikuo Horigome 350 70 72 131 25 479

All Works

Loading papers...

Rankless by CCL
2026